Early virological response in six patients with hepatitis D virus infection and compensated cirrhosis treated with Bulevirtide in real‐life
Sign Up to like & getrecommendations! Published in 2021 at "Liver International"
DOI: 10.1111/liv.14950
Abstract: Hepatitis delta virus (HDV) infection is the most severe form of viral hepatitis. Bulevirtide (BLV, Hepcludex®) is an HDV/HBV entry inhibitor approved in June 2020 in the European Union for adult patients with chronic hepatitis… read more here.
Keywords: hepatitis; treatment; six patients; hdv ... See more keywords